Envoy Medical's CEO Brent Lucas will present at the H.C. Wainwright 28th Annual Global Investment Conference on September 15, 2026, showcasing the company's innovative fully implanted hearing solutions, including the Esteem active middle ear implant and the investigational Acclaim cochlear implant. These devices represent advancements in hearing technology, offering improved usability and quality of life for those with hearing loss. The Acclaim implant has FDA Breakthrough Device status and targets severe hearing loss, while the Esteem implant is FDA-approved for moderate to severe loss. The presentation will be webcast and available on demand for 90 days, highlighting Envoy's commitment to pushing hearing health technology forward.
Nvidia has returned a record $26 billion to its shareholders after increasing its dividend by an extraordinary 2,400%. This massive payout highlights the company's strong financial position and commitment to rewarding investors. The significant divid...
Paying off a $10,000 credit card balance at once eliminates roughly $2,100 in annual interest at an average 21% APR, effectively giving a high return on your money. While your credit score won't update immediately, your credit utilization ratio drops...
Chase offers three standout credit cards for 2026: the Chase Sapphire Preferred® Card for travel rewards with a $95 annual fee and strong bonus points; the Chase Freedom Unlimited® for cash back with no annual fee and a $200 sign-up bonus; and the Ch...
In September 2026, several banks offer high-yield savings accounts with attractive APYs without requiring direct deposit. Barclays Tiered Savings provides a straightforward 3.50% APY for balances under $250,000 with no minimum or fees. CIT Platinum S...
Actabl's AI Insights for Hotel Effectiveness, launched in June 2026, helps U.S. hotels reduce labor costs by identifying scheduling and overtime issues early. Over 100 hotels using the platform have seen a 13% average drop in overtime hours and signi...
